Masahiro Doi

1.9k total citations
29 papers, 1.5k citations indexed

About

Masahiro Doi is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology and Pathology and Forensic Medicine. According to data from OpenAlex, Masahiro Doi has authored 29 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Cardiology and Cardiovascular Medicine, 17 papers in Molecular Biology and 4 papers in Pathology and Forensic Medicine. Recurrent topics in Masahiro Doi's work include Cardiac electrophysiology and arrhythmias (22 papers), Ion channel regulation and function (17 papers) and Cardiac pacing and defibrillation studies (6 papers). Masahiro Doi is often cited by papers focused on Cardiac electrophysiology and arrhythmias (22 papers), Ion channel regulation and function (17 papers) and Cardiac pacing and defibrillation studies (6 papers). Masahiro Doi collaborates with scholars based in Japan, United States and Russia. Masahiro Doi's co-authors include Masunori Matsuzaki, Shinichi Okuda, Masafumi Yano, Shigeki Kobayashi, Tomoko Ohkusa, T Tokuhisa, Tetsuro Oda, Takeshi Yamamoto, Hiroki Tateishi and Noriaki Ikemoto and has published in prestigious journals such as Circulation, PLoS ONE and Circulation Research.

In The Last Decade

Masahiro Doi

29 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Masahiro Doi Japan	20	1.2k	1.1k	207	98	65	29	1.5k
Tetsuro Oda Japan	21	1.2k 0.9×	1.1k 1.0×	150 0.7×	103 1.1×	57 0.9×	71	1.5k
Zhaokang Yang United Kingdom	16	631 0.5×	566 0.5×	159 0.8×	62 0.6×	88 1.4×	21	951
Bruno Gavillet Switzerland	16	495 0.4×	754 0.7×	172 0.8×	39 0.4×	82 1.3×	25	966
Jiqing Guo Canada	18	619 0.5×	689 0.6×	197 1.0×	18 0.2×	23 0.4×	29	871
Julio Altamirano Mexico	13	267 0.2×	430 0.4×	167 0.8×	36 0.4×	65 1.0×	20	653
Ralph Bosch Germany	20	2.3k 1.9×	943 0.8×	226 1.1×	43 0.4×	30 0.5×	62	2.5k
Florence Lefebvre France	15	463 0.4×	684 0.6×	98 0.5×	45 0.5×	116 1.8×	22	928
Michelle M. Monasky Italy	21	889 0.7×	704 0.6×	89 0.4×	61 0.6×	64 1.0×	59	1.3k
Candice Thomas United States	15	428 0.3×	480 0.4×	47 0.2×	33 0.3×	137 2.1×	17	896
Hideo Otani Japan	15	640 0.5×	632 0.6×	119 0.6×	151 1.5×	32 0.5×	22	905

Countries citing papers authored by Masahiro Doi

Since Specialization

Citations

This map shows the geographic impact of Masahiro Doi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Masahiro Doi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Masahiro Doi more than expected).

Fields of papers citing papers by Masahiro Doi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Masahiro Doi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Masahiro Doi. The network helps show where Masahiro Doi may publish in the future.

Co-authorship network of co-authors of Masahiro Doi

This figure shows the co-authorship network connecting the top 25 collaborators of Masahiro Doi. A scholar is included among the top collaborators of Masahiro Doi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Masahiro Doi. Masahiro Doi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Narita, Kentaro, So Nakaji, Rikako Tabata, et al.. (2022). Antibody response to COVID-19 vaccination in patients with lymphoma. International Journal of Hematology. 115(5). 728–736. 11 indexed citations

Terao, Toshiki, Takeshi Yamashita, Daisuke Ikeda, et al.. (2022). Low clinical protective response to SARS-CoV-2 mRNA COVID-19 vaccine in patients with multiple myeloma. International Journal of Hematology. 115(5). 737–747. 6 indexed citations

Kobayashi, Shigeki, Hironori Ishiguchi, Wakako Murakami, et al.. (2015). Urinary 8-hydroxy-2′-deoxyguanosine as a novel biomarker of inflammatory activity in patients with cardiac sarcoidosis. International Journal of Cardiology. 190. 319–328. 23 indexed citations

Kobayashi, Shigeki, Takehisa Susa, Hironori Ishiguchi, et al.. (2015). A Low-Dose β1-Blocker in Combination with Milrinone Improves Intracellular Ca2+ Handling in Failing Cardiomyocytes by Inhibition of Milrinone-Induced Diastolic Ca2+ Leakage from the Sarcoplasmic Reticulum. PLoS ONE. 10(1). e0114314–e0114314. 20 indexed citations

Kobayashi, Shigeki, Wakako Murakami, Hiroki Tateishi, et al.. (2013). A Low-Dose β<sub>1</sub>-Blocker Effectively and Safely Slows the Heart Rate in Patients with Acute Decompensated Heart Failure and Rapid Atrial Fibrillation. Cardiology. 127(2). 105–113. 31 indexed citations

Hiratsuka, Atsushi, Akihiko Shimizu, Takeshi Ueyama, et al.. (2012). The Difference of Ventricular Fibrillation Cycle Length in Patients between with Symptomatic and Asymptomatic Brugada Syndrome. Circulation. 76. 123. 1 indexed citations

Shimizu, Akihiko, Takeshi Ueyama, Yasuhiro Yoshiga, et al.. (2012). Effects of isoproterenol and propranolol on the inducibility and frequency of ventricular fibrillation in patients with Brugada syndrome. Journal of Cardiology. 60(1). 47–54. 13 indexed citations

Hino, Akihiro, Masafumi Yano, Takayoshi Kato, et al.. (2012). Enhanced binding of calmodulin to the ryanodine receptor corrects contractile dysfunction in failing hearts. Cardiovascular Research. 96(3). 433–443. 25 indexed citations

Kobayashi, Shigeki, Takehisa Susa, Takeo Tanaka, et al.. (2012). Low-Dose β-Blocker in Combination With Milrinone Safely Improves Cardiac Function and Eliminates Pulsus Alternans in Patients With Acute Decompensated Heart Failure. Circulation Journal. 76(7). 1646–1653. 40 indexed citations

10.

Susa, Takehisa, Shigeki Kobayashi, Takeo Tanaka, et al.. (2011). Urinary 8-Hydroxy-2'-Deoxyguanosine as a Novel Biomarker for Predicting Cardiac Events and Evaluating the Effectiveness of Carvedilol Treatment in Patients With Chronic Systolic Heart Failure. Circulation Journal. 76(1). 117–126. 25 indexed citations

11.

Kobayashi, Shigeki, Takehisa Susa, Takeo Tanaka, et al.. (2010). Urinary 8-Hydroxy-2′-Deoxyguanosine Reflects Symptomatic Status and Severity of Systolic Dysfunction in Patients with Chronic Heart Failure. European Journal of Heart Failure. 13(1). 29–36. 53 indexed citations

12.

Shimizu, Akihiko, Takeshi Ueyama, Yasuhiro Yoshiga, et al.. (2010). What variables were associated with the inducibility of ventricular fibrillation during electrophysiologic stimulation test in patients without apparent organic heart disease?. Journal of Cardiology. 56(1). 35–43. 3 indexed citations

13.

Ono, Makoto, Masafumi Yano, Akihiro Hino, et al.. (2010). Dissociation of calmodulin from cardiac ryanodine receptor causes aberrant Ca2+ release in heart failure. Cardiovascular Research. 87(4). 609–617. 64 indexed citations

14.

Xu, Xiaojuan, Masafumi Yano, Hitoshi Uchinoumi, et al.. (2010). Defective calmodulin binding to the cardiac ryanodine receptor plays a key role in CPVT-associated channel dysfunction. Biochemical and Biophysical Research Communications. 394(3). 660–666. 66 indexed citations

15.

Uchinoumi, Hitoshi, Masafumi Yano, Takeshi Suetomi, et al.. (2010). Catecholaminergic Polymorphic Ventricular Tachycardia Is Caused by Mutation-Linked Defective Conformational Regulation of the Ryanodine Receptor. Circulation Research. 106(8). 1413–1424. 121 indexed citations

16.

Hayashi, Takeharu, Maryann E. Martone, Zeyun Yu, et al.. (2009). Three-dimensional electron microscopy reveals new details of membrane systems for Ca2+ signaling in the heart. Journal of Cell Science. 122(7). 1005–1013. 194 indexed citations

17.

Yano, Masafumi, Shinichi Okuda, Tetsuro Oda, et al.. (2005). Correction of Defective Interdomain Interaction Within Ryanodine Receptor by Antioxidant Is a New Therapeutic Strategy Against Heart Failure. Circulation. 112(23). 3633–3643. 95 indexed citations

18.

Okuda, Shinichi, Masafumi Yano, Masahiro Doi, et al.. (2004). Valsartan Restores Sarcoplasmic Reticulum Function With No Appreciable Effect on Resting Cardiac Function in Pacing-Induced Heart Failure. Circulation. 109(7). 911–919. 36 indexed citations

19.

Shimizu, Akihiko, et al.. (2003). New Method of Determining the Atrial Fibrillation Cycle Length During Human Atrial Fibrillation. Journal of Cardiovascular Electrophysiology. 14(9). 965–970. 4 indexed citations

20.

Ishii, Masao, Tokuichiro Sugimoto, Keiichiro Atarashi, et al.. (1983). Effects of high salt intake on hemodynamic responses to isometric exercise in normotensive subjects and in patients with essential hypertension.. Japanese Circulation Journal. 47(10). 1248–1254. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact